Pharmafile Logo
Pharmafocus logo
Advanced Search
512px-oxford_university_colleges-all_souls1

AstraZeneca and Oxford University’s COVID-19 vaccine generates “robust immune responses” in early interim data

July 21, 2020
Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Oxford University, Vaccine, coronavirus

Interim Phase 1/2 findings have been released for the COVID-19 highly anticipated vaccine candidate in development from Oxford University and …

News
stock_image_drugs

Fujifilm to begin clinical trials testing Avigan in COVID-19 patients in Kuwait

July 21, 2020
Manufacturing and Production COVID-19, Fujifilm, Japan, avigan, coronavirus

Fujifilm will begin clinical trials investigating the effectiveness of Avigan in treating coronavirus patients in Kuwait. The trials will be …

News

North Korea says it’s developing its own coronavirus vaccine

July 21, 2020
Manufacturing and Production COVID-19, North Korea, coronavirus

North Korea has announced it is developing a vaccine against COVID-19. The announcement was made on 18 July by the …

News

Is Pharma doing enough on sustainability?

July 20, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antimicrobial resistance, manufacturing, pharma, sustainability

Adoption of sustainable practices in pharmaceutical operations is ticking along, but given the environmental and health risks if this is …

Feature
mylan_building

Mylan launches generic version of Gilead’s remdesivir for COVID-19 patients in India

July 20, 2020
Sales and Marketing COVID-19, Gilead, India, Mylan, generic, remdesivir

Mylan has launched its own generic version of Gilead’s remdesivir on the Indian market for the treatment of patients with …

News
shutterstock_36423250

Synairgen drug doubles likelihood of recovery in hospitalised COVID-19 patients, early data show

July 20, 2020
Research and Development, Sales and Marketing COVID-19, Synairgen

Respiratory drug firm Synairgen has, like many, been hard at work on a treatment for patients with COVID-19; the company …

News
israel

Israeli doctor tests positive for coronavirus 3 months after recovering

July 20, 2020
Sales and Marketing COVID-19, coronavirus

An Israeli doctor has appeared to have contracted COVID-19 for a second time after they tested positive for the virus …

News
1200px-gdpr_europe

England’s test and trace system breaks GDPR data law, according to privacy group

July 20, 2020
Sales and Marketing Contact tracing, GDPR, coronavirus, covid19

England’s test and trace programme broke General Data Protection Regulation (GDPR) data law according to the Open Rights Group (ORG). …

News
british_parliament_14749841802

UK secures early access to 90 million doses of coronavirus vaccines

July 20, 2020
Sales and Marketing COVID-19, coronaviurs, vaccines

The UK has secured early access to 90 million doses of coronavirus vaccines through multiple partnerships with pharmaceutical companies.

News

Innate Pharma announces new Executive Vice President and Chief Medical Officer

July 17, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Innate Pharma, appointment

Innate Pharma has named Dr Joyson Karakunnel as its new Executive Vice President and Chief Medical Officer (CMO), with current …

Appointment
astrazeneca_sign_sky

AstraZeneca secures accelerated FDA review for Farxiga for for CV death following heart attacks

July 17, 2020
Medical Communications, Research and Development, Sales and Marketing AstraZeneca, FDA, farxiga, fast track

AstraZeneca has made it known that Farxiga (dapagliflozin) has secured Fast Track Designation from the FDA for the reduction of …

News
800px-smallpox_vaccine

WHO reports “alarming decline” in child vaccinations due to COVID-19 disruption

July 17, 2020
Medical Communications, Sales and Marketing COVID-19, WHO, vaccination, vaccines

The World Health Organization and UNICEF have pointed to an “alarming decline” in the levels of children worldwide receiving essential …

News
fda

FDA grants fast review for Bayer and MSD’s heart failure drug vericiguat

July 17, 2020
Medical Communications Bayer, FDA, MSD

The FDA has granted a fast Priority Review for Bayer and MSD’s heart failure drug vericiguat. This was based on …

News
remsssy

Hydroxychloroquine proves ineffective against COVID-19 in newest trial

July 17, 2020
Medical Communications COVID-19, coronavirus, hydroxychloroquine

The newest clinical trial into hydroxychloroquine has proved unsuccessful in treating coronavirus patients. A recent study was published in the …

News
top_10_image_2_3

Top Ten most popular articles on Pharmafile.com this week

July 17, 2020
Medical Communications top 10

The news this week as usual centres on treatments and vaccines for COVID-19, with Russia claiming it is the first …

News
Doctor online

COVID-19 is pushing healthcare firms to embrace digital transformation, reports suggest

July 16, 2020
Medical Communications, Research and Development digital, healthcare, pharma

The COVID-19 pandemic forced industries across the board to evolve or die with regard to their approach to digital working …

News
az

AstraZeneca’s Brilinta reduces the rate of stroke and death in patients with acute ischaemic stroke or transient ischaemic attack

July 16, 2020
Business Services AZ, AstraZeneca, drug trials

AstraZeneca’s Phase 3 THALES trial showed that Brilinta (ticagrelor) significantly reduced the rate of death or stroke in patients with …

News

Novartis to provide ‘no-profit’ generics to low income countries to help combat COVID-19

July 16, 2020
Business Services COVID-19, Novartis, coronavirus, hydroxychloroquine

The Sandoz division of Novartis will not make a profit on the 15 generics it is making available to developing …

News

Trump administration orders hospitals to stop sending COVID-19 data to the CDC

July 16, 2020
Business Services CDC, COVID, coronavirus

The Trump administration has ordered hospitals to stop sending coronavirus patient data to the Centers for Disease Control and Prevention …

News

Gilteritinib becomes first NICE-approved oral therapy for relapsed or refractory acute myeloid leukaemia

July 16, 2020
Sales and Marketing Atellas, NICE, UK, acute myeloid leukaemia, gilteritinib

NICE has revealed its recommendation of Astellas’ gilteritinib for routine use as a monotherapy on the NHS in England and …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026